Kenzo Iizuka
Chief Tech/Sci/R&D Officer chez DELTA-FLY PHARMA, INC.
Fortune : 472 893 $ au 31/03/2024
Profil
Kenzo Iizuka is currently the Director, Head-Research & Development at Delta-Fly Pharma, Inc. He previously worked as a Manager-Third Development at Taiho Pharmaceutical Co., Ltd.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
DELTA-FLY PHARMA, INC.
1,03% | 31/03/2023 | 85 000 ( 1,03% ) | 472 893 $ | 31/03/2024 |
Postes actifs de Kenzo Iizuka
Sociétés | Poste | Début |
---|---|---|
DELTA-FLY PHARMA, INC. | Chief Tech/Sci/R&D Officer | 01/06/2017 |
Anciens postes connus de Kenzo Iizuka
Sociétés | Poste | Fin |
---|---|---|
Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiho Pharmaceutical Co., Ltd. engages in the production of drugs and medical products. It researches, innovates, and develops pharmaceuticals for various diseases. The company was founded on June 1, 1963 and is headquartered in Tokyo, Japan. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
DELTA-FLY PHARMA, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiho Pharmaceutical Co., Ltd. engages in the production of drugs and medical products. It researches, innovates, and develops pharmaceuticals for various diseases. The company was founded on June 1, 1963 and is headquartered in Tokyo, Japan. | Health Technology |